K. Harada

发表

Clinical Pharmacology of Multiple‐Dose Losartan, an Angiotensin II Receptor Antagonist, in Patients with Essential Hypertension

A. Fujimura, A. Ebihara, M. Sasaki, 1996, Journal of clinical pharmacology.

Influences of Bathing and Hot Weather on the Pharmacokinetics of a New Transdermal Clonidine, M‐5041T

A. Fujimura, K. Ohashi, Y. Kumagai, 1996, Journal of clinical pharmacology.

ANGIOTENSIN II IN HUMAN VEINS: DEVELOPMENT OF RAPID DESENSITIZATION AND EFFECT OF INDOMETHACIN

A. Fujimura, M. Ohmori, K. Harada, 1999, Clinical and experimental pharmacology & physiology.

Polymorphonuclear leukocytes (PMNs) functions in SHR, l‐NAME‐ and DOCA/salt‐induced hypertensive rats

A. Fujimura, M. Ohmori, K. Harada, 2000, Journal of hypertension.

Effect of angiotensin II on venodilator response to nitroglycerin

A. Fujimura, M. Ohmori, K. Harada, 2001, Clinical pharmacology and therapeutics.

Antagonistic activity of tamsulosin against human vascular α1‐adrenergic receptors

A. Fujimura, M. Ohmori, K. Harada, 2000, Clinical pharmacology and therapeutics.

A comparison of the antagonistic activities of tamsulosin and terazosin against human vascular alpha1-adrenoceptors.

A. Fujimura, M. Ohmori, K. Harada, 1999, Japanese journal of pharmacology.

The Effect of Diltiazem on Hepatic Drug Oxidation Assessed by Antipyrine and Trimethadione

A. Fujimura, K. Ohashi, A. Ebihara, 1991, Journal of clinical pharmacology.

Comparison of Venodilatory Effect of Amrinone and Theophylline In Human Subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 1995, Journal of clinical pharmacology.

Furosemide‐probenecid interaction as a laboratory exercise for undergraduate education in clinical pharmacology

A. Fujimura, S. Tsuruoka, E. Kobayashi, 2001, Clinical pharmacology and therapeutics.

Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity.

E. Kobayashi, A. Fujimura, K. Fuse, 2000, Artificial organs.